Horváth K M, Meerlo P, Felszeghy K, Nyakas C, Luiten P G
Department of Animal Physiology, Graduate School of Behavioural and Cognitive Neurosciences, University of Groningen, Haren, The Netherlands.
Behav Brain Res. 1999 Dec;106(1-2):181-8. doi: 10.1016/s0166-4328(99)00106-0.
Studies on adult animals and humans have shown that the ACTH4-9 analog ORG 2766 influences cognitive performance and possibly has neurotrophic effects. For this reason we studied the effect of ORG 2766 applied in early postnatal life when brain structures and neuronal pathways are still developing. Our aim was to see whether such treatment during development would result in permanent changes in adult behavioural performance. Pups received subcutaneous injections of 1 microg/g bodyweight ACTH4-9 analog ORG 2766 on day 1, 3 and 5 after birth. Control animals in the same nest received saline injections. When the animals had reached an adult age of 3 months they were subjected to a series of tests to measure their behavioural performance. In the first experiment, behavioural stress responses and anxiety were measured by subjecting the rats to the following tests: open field, defensive burying, elevated plus maze, and conditioned fear test. In a second experiment, adult cognitive function was measured in the Morris water-maze, a hippocampus-related spatial learning test, and in the active avoidance test, a more amygdala-related nonspatial test. The results showed that animals treated with ORG 2766 during early postnatal life learned faster in the spatial Morris water-maze. The treatment had a positive effect on performance during the acquisition phase of the learning task, while memory retrieval was not affected. Learning in the nonspatial active avoidance task did not change due to the postnatal ACTH4-9 treatment. In addition, there were no differences in the open field test, the defensive burying test, elevated plus maze and the conditioned fear test. The latter supports the conclusion that the differences in water-maze performance was due to a difference in learning speed, rather than a difference in anxiety or behavioural stress reactivity. Analysis of [3H]CORT binding capacity measured after the learning tests revealed no differences in the hippocampal MR and GR concentration between non-treated and treated animals.
对成年动物和人类的研究表明,促肾上腺皮质激素4-9类似物ORG 2766会影响认知能力,并且可能具有神经营养作用。因此,我们研究了在出生后早期生命阶段(此时脑结构和神经通路仍在发育)应用ORG 2766的效果。我们的目的是观察发育期间的这种治疗是否会导致成年行为表现的永久性变化。幼崽在出生后第1、3和5天接受皮下注射1微克/克体重的促肾上腺皮质激素4-9类似物ORG 2766。同一窝中的对照动物接受生理盐水注射。当动物达到3个月成年年龄时,对它们进行一系列测试以测量其行为表现。在第一个实验中,通过对大鼠进行以下测试来测量行为应激反应和焦虑:旷场试验、防御性埋埋试验、高架十字迷宫试验和条件性恐惧试验。在第二个实验中,在莫里斯水迷宫(一种与海马体相关的空间学习测试)和主动回避试验(一种与杏仁核相关的非空间测试)中测量成年认知功能。结果表明,在出生后早期接受ORG 2766治疗的动物在空间莫里斯水迷宫中的学习速度更快。该治疗对学习任务获取阶段的表现有积极影响,而记忆检索未受影响。出生后促肾上腺皮质激素4-9治疗并未改变非空间主动回避任务中的学习情况。此外,在旷场试验、防御性埋埋试验、高架十字迷宫试验和条件性恐惧试验中没有差异。后者支持这样的结论,即水迷宫表现的差异是由于学习速度的差异,而不是焦虑或行为应激反应性的差异。学习测试后测量的[3H]皮质醇结合能力分析显示,未治疗和治疗动物之间海马体盐皮质激素受体和糖皮质激素受体浓度没有差异。